Biomedical research in Ecuador 2016 – 2024: a scoping review of trends, gaps and policy implications
DOI:
https://doi.org/10.29166/rfcmq.v51i2.9215Keywords:
translational Biomedical Research, biomedical research, Ecuador, scoping review, health policyAbstract
Introduction: Biomedical research is essential for advancing global health; however, disparities persist between high-income countries and low- and middle-income countries regarding scientific production and innovation. In this context, Ecuador faces limitations such as insufficient funding, limited specialized infrastructure, and weak alignment between research and national health priorities. Although some progress and international collaborations exist, biomedical production remains limited in addressing infectious and chronic diseases. This scoping review analyzes translational biomedical research conducted in Ecuador between 2016 and 2024, identifying gaps and challenges to strengthen innovation and support public health decision-making.
Objectives: To map and analyze translational biomedical research published in Ecuador between 2016 and 2024 and identify knowledge gaps and challenges affecting its national applicability.
Methods: A scoping review was conducted following PRISMA-ScR guidelines. Searches were performed in PubMed, Scielo, LILACS, ClinicalTrials.gov, and Cochrane Library using terms related to biomedical research in Ecuador. Studies published in English or Spanish between 2016 and 2024 were included. Three independent reviewers assessed the studies, and a thematic analysis was performed.
Results: Nineteen studies were included. Infectious diseases represented the main research focus (n=9), particularly in post-pandemic contexts. Gastroenterology was another relevant field (n=6), emphasizing minimally invasive innovative interventions. Additional areas included nutrition, traumatology, microbiology, and oncology. Fifteen clinical trials were identified; although nine were completed, only four reported published results, limiting efficacy assessment and evidence availability.
Conclusions: Biomedical research in Ecuador remains fragmented and underrepresented globally. Strengthening research capacity, increasing funding, and promoting the publication of clinical trial results are essential to enhance the country’s scientific and public health impact.
Downloads
Metrics
References
1. World Health Organization. WHO launches guide to safely unlock benefits of the life sciences [Internet]. Geneva: WHO; 2022 [citado 26 de junio de 2025]. Disponible en: https://www.who.int/news/item/13-09-2022-who-launches-guide-to-safely-unlock-benefits-of-the-life-sciences
2. Burotto M, Prasad V. Emphasizing unique strengths and eliminating redundancy for research in low-income and middle-income countries: Lessons from a South American country. Cancer [Internet]. 2015 [citado 26 de junio de 2025];121(16):2668-2670. Disponible en: doi:10.1002/CNCR.29408
3. Oppong FC. Innovation in income-poor environments. Br J Surg [Internet]. 2015 [citado 26 de junio de 2025];102(2):e102-e107 Disponible en: doi:10.1002/BJS.9712
4. Ishimwe MCS, Kiplagat J, Kadam Knowlton A, Livinski AA, Kupfer LE. Reversing the trend: a scoping review of health innovation transfer or exchange from low- and middle-income countries to high-income countries. BMJ Glob Heal [Internet]. 2023 [citado 26 de junio de 2025];8(Suppl 7):13583. Disponible en: doi:10.1136/BMJGH-2023-013583
5. Ministerio de Salud Pública del Ecuador. Plan Estratégico Institucional 2019-2021 [Internet]. Quito: MSP; 2019 [citado 26 de junio de 2025]. Disponible en: https://aplicaciones.msp.gob.ec/salud/archivosdigitales/documentosDirecciones/dnn/archivos/AC-00070-2019NOV19.pdf
6. Pan American Health Organization. Perfil de país - Ecuador | Salud en las Américas [Internet]. Washington, DC: PAHO; 2024 [citado 26 de junio de 2025]. Disponible en: https://hia.paho.org/es/perfiles-de-pais/ecuador
7. Castillo JA, Powell MA. Research Productivity and International Collaboration: A Study of Ecuadorian Science. J Hispanic High Educ [Internet]. 2020 [citado 26 de junio de 2025];19(4):369-387 Disponible en: doi:10.1177/1538192718792151
8. López-Cevallos DF, Chi C. Health care utilization in Ecuador: a multilevel analysis of socio-economic determinants and inequality issues. Health Policy Plan [Internet]. 2010 [citado 26 de junio de 2025];25(3):209-218. Disponible en: doi:10.1093/HEAPOL/CZP052
9. Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A. Rayyan-a web and mobile app for systematic reviews. Syst Rev [Internet]. 2016 [citado 26 de junio de 2025];5(1):1-10 Disponible en: doi:10.1186/S13643-016-0384-4/FIGURES/6
10. University of Oxford Centre for Evidence-Based Medicine. Oxford Centre for Evidence-Based Medicine: Levels of Evidence [Internet]. Oxford: CEBM; 2009 [citado 26 de junio de 2025]. Disponible en: https://www.cebm.ox.ac.uk/resources/levels-of-evidence/oxford-centre-for-evidence-based-medicine-levels-of-evidence-march-2009
11. Cambrosio A, Keating P. Biomedical Sciences and Technology: History and Sociology. Int Encycl Soc Behav Sci [Internet]. 2001 [citado 26 de junio de 2025]:1222-1226. Disponible en: doi:10.1016/B0-08-043076-7/03143-0
12. National Cancer Institute. Definition of biomedicine [Internet]. Bethesda (MD): NCI; 2025 [citado 26 de junio de 2025]. Disponible en: https://www.cancer.gov/publications/dictionaries/cancer-terms/def/biomedicine
13. Lasky J. Biomedicine [Internet]. Ipswich (MA): EBSCO; 2023 [citado 1 de abril de 2026]. Disponible en: https://www.ebsco.com/research-starters/health-and-medicine/biomedicine
14. Robles-Medranda C. Hyaluronic acid in patients with gastroesophageal reflux disease [Internet]. ClinicalTrials.gov; 2023 [citado 17 de febrero de 2025]. Identificador NCT05561179. Disponible en: https://clinicaltrials.gov/study/NCT05561179
15. Robles-Medranda C. Treatment of gastric varices using EUS guided techniques [Internet]. ClinicalTrials.gov; 2019 [citado 17 de febrero de 2025]. Identificador NCT03155256. Disponible en: https://clinicaltrials.gov/study/NCT03155256
16. Robles-Medranda C. EUS-guided combined therapy versus beta blocker therapy in primary prophylaxis of GOV II and IGV I [Internet]. ClinicalTrials.gov; 2019 [citado 17 de febrero de 2025]. Identificador NCT04075760. Disponible en: https://clinicaltrials.gov/study/NCT04075760
17. Robles-Medranda C. Primary EUS-GBD in patients with unresectable malignant biliary obstruction and cystic duct orifice involvement [Internet]. ClinicalTrials.gov; 2020 [citado 17 de febrero de 2025]. Identificador NCT03729882. Disponible en: https://clinicaltrials.gov/study/NCT03729882
18. Iannotti L. LULUN PROJECT II - Cohort follow-up study [Internet]. ClinicalTrials.gov; 2019 [citado 17 de febrero de 2025]. Identificador NCT03902145. Disponible en: https://clinicaltrials.gov/study/NCT03902145
19. Catalysis SL. Safety and efficacy of Viusid and Asbrip in hospitalized patients infected by SARS-Cov-2 with COVID-19 [Internet]. ClinicalTrials.gov; 2021 [citado 17 de febrero de 2025]. Identificador NCT04407182. Disponible en: https://clinicaltrials.gov/study/NCT04407182
20. Loria Kohen V, González-Rodríguez LG, Bermejo López LM, Aparicio A, López-Sobaler AM. Recommended egg intake in children: past, present, and future. Nutr Hosp [Internet]. 2022 [citado el 26 de junio 2025] Disponible en: doi:10.20960/nh.04311
21. National Cancer Institute. Patrocinador de un ensayo clínico [Internet]. Bethesda (MD): NCI; 2025 [citado 18 de febrero de 2025]. Disponible en: https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/patrocinador-de-un-ensayo-clinico
22. Pfizer. A retrospective medical record review of first-line sunitinib administration schedules and outcomes among patients with mRCC in Latin America (LA) [Internet]. ClinicalTrials.gov; 2022 [citado 26 de junio de 2025]. Identificador NCT04115189. Disponible en: https://clinicaltrials.gov/study/NCT04115189
23. Peñas‐Herrero I, de la Serna‐Higuera C, Perez‐Miranda M. Endoscopic ultrasound‐guided gallbladder drainage for the management of acute cholecystitis (with video). J Hepatobiliary Pancreat Sci [Internet]. 2015 [citado 26 de junio de 2025];22(1):35-43. Disponible en: doi:10.1002/jhbp.182
24. Sisa I, Caicedo-Potosí J, Cordovez M, et al. One hundred years of Ecuadorian biomedical scientific output and its association with the main causes of mortality: a bibliometric study. Front Med [Internet] 2024 [citado 26 de junio de 2025];11:1395433 Disponible en: doi:10.3389/FMED.2024.1395433/BIBTEX
25. Ciocca DR, Delgado G. The reality of scientific research in Latin America; an insider’s perspective. Cell Stress Chaperones [Internet]. 2017 [citado 26 de junio de 2025];22(6):847-852 Disponible en: doi:10.1007/S12192-017-0815-8
26. Aliukonis V, Poškutė M, Gefenas E. Perish or Publish Dilemma: Challenges to Responsible Authorship. Med [Internet]. 2020 [citado 26 de junio de 2025];56(3):123. Disponible en: doi:10.3390/MEDICINA56030123
27. Barreto SM, Miranda JJ, Figueroa JP, et al. Epidemiology in Latin America and the Caribbean: current situation and challenges. Int J Epidemiol [Internet]. 2012 [citado 26 de junio de 2025];41(2):557-571 Disponible en: doi:10.1093/IJE/DYS017
28. Zambrano Mendoza JL. La sociedad del conocimiento: cantidad, categoría y género de los investigadores en Ecuador. Mundos Plur - Rev Latinoam Políticas y Acción Pública [Internet]. 2020 [citado 26 de junio de 2025];6(1):73-92 Disponible en: doi:10.17141/mundosplurales.1.2019.3855
29. Márquez S, Molina M, Ortiz D, Ordóñez R. Prevalencia de enfermedades crónicas no transmisibles. Ser Científica. 2022;15(2):127-37.
30. Macías Moreira MG, Ortega Baldeon GA, Azúa Menéndez M del J. Enfermedades crónicas no transmisibles y la calidad de vida en el Ecuador. MQRInvestigar [Internet]. 2023 [citado 26 de junio de 2025];7(1):1592-1612. Disponible en: doi:10.56048/mqr20225.7.1.2023.1592-1612
31. Terán E. Isoprinosine in HIV patients with viral load > 50 y < 200 copies/mL [Internet]. ClinicalTrials.gov; 2019 [citado 26 de junio de 2025]. Identificador NCT03883334. Disponible en: https://clinicaltrials.gov/study/NCT03883334
32. Vélez-Páez JL, Baldeón-Rojas L, Cañadas Herrera C, et al. Receiver operating characteristic (ROC) to determine cut-off points of clinical and biomolecular markers to discriminate mortality in severe COVID-19 living at high altitude. BMC Pulm Med [Internet]. 2023 [citado 26 de junio de 2025];23(1):393. Disponible en: doi:10.1186/s12890-023-02691-2
33. Cherrez I. Efficacy and safety of phototherapy in the treatment of loss of smell post acute infection of Coronavirus 19 [Internet]. ClinicalTrials.gov; 2022 [citado 17 de febrero de 2025]. Identificador NCT05177445. Disponible en: https://clinicaltrials.gov/study/NCT05177445
34. Ministerio de Salud Pública del Ecuador. Documentación del subproceso gestión del sistema integrado de vigilancia epidemiológica. Quito: MSP; 2025.
35. Chiriboga Accini C. Bone marrow versus adipose autologous mesenchymal stem cells for the treatment of knee osteoarthritis [Internet]. ClinicalTrials.gov; 2020 [citado 26 de junio de 2025]. Identificador NCT04351932. Disponible en: https://clinicaltrials.gov/study/NCT04351932
36. Jaramillo-Riofrío A, Decock C, Suárez JP, Benítez Á, Castillo G, Cruz D. Screening of Antibacterial Activity of Some Resupinate Fungi, Reveal Gloeocystidiellum lojanense sp. nov. (Russulales) against E. coli from Ecuador. J Fungi [Internet]. 2022 [citado 17 de febrero de 2025];9(1):54. Disponible en: doi:10.3390/jof9010054
37. Bedoya-Pilozo CH, Medina Magües LG, Espinosa-García M, et al. Molecular epidemiology and phylogenetic analysis of human papillomavirus infection in women with cervical lesions and cancer from the coastal region of Ecuador. Rev Argent Microbiol [Internet]. 2018 [citado 17 de febrero de 2025];50(2):136-146. Disponible en: doi:10.1016/j.ram.2017.06.004
38. Robles-Medranda C. Feasibility, safety, and efficacy of EUS-guided thermal radiofrequency ablation in the treatment of gastrointestinal stromal tumors [Internet]. ClinicalTrials.gov; 2023 [citado 5 de agosto de 2025]. Identificador NCT05453292. Disponible en: https://clinicaltrials.gov/study/NCT05453292
39. Novotney-Barry A. A double-blind placebo controlled, randomized, phase II study to assess the safety, tolerability, pharmacokinetics and efficacy of twice daily topical applications of AP611074 5% gel for up to 16 weeks in condyloma patients [Internet]. ClinicalTrials.gov; 2018 [citado 5 de agosto de 2025]. Identificador NCT02724254. Disponible en: https://clinicaltrials.gov/study/NCT02724254
40. Whitlock R, Belley-Cote E, Eikelboom J. Anti-coronavirus therapies to prevent progression of COVID-19, a randomized trial [Internet]. ClinicalTrials.gov; 2024 [citado 5 de agosto de 2025]. Identificador NCT04333420. Disponible en: https://clinicaltrials.gov/study/NCT04333420
41. Teran E. Effect of high doses of vitamin C on the tissular reparation (healing) in patients under surgery in the “Hospital de Los Valles” [Internet]. ClinicalTrials.gov; 2021 [citado 5 de agosto de 2025]. Identificador NCT04896359. Disponible en: https://clinicaltrials.gov/study/NCT04896359
42. Atea Pharmaceuticals I. A phase 2, randomized, double-blind, placebo-controlled, dose-ranging trial to evaluate pharmacokinetics, pharmacodynamics, and safety of AT-752 in patients with dengue infection [Internet]. ClinicalTrials.gov; 2024 [citado 5 de agosto de 2025]. Identificador NCT05466240. Disponible en: https://clinicaltrials.gov/study/NCT05466240
43. Buzzá HH, Silva AP da, Vollet Filho JD, et al. Photodynamic therapy: Progress toward a scientific and clinical network in Latin America. Photodiagnosis Photodyn Ther. [Internet]. 2016 [citado 5 de agosto de 2025];13:261-266. Disponible en: doi:10.1016/j.pdpdt.2015.08.004
44. World Health Organization. Number of clinical trials by year, country, WHO region and income group (1999-2022) [Internet]. Geneva: WHO; 2026 [citado 21 de enero de 2026]. Disponible en: https://www.who.int/observatories/global-observatory-on-health-research-and-development/monitoring/number-of-clinical-trials-by-year-country-who-region-and-income-group
45. Sisa I, Espinel M, Fornasini M, Mantilla G. La producción científica en ciencias de la salud en Ecuador. Rev Panam Salud Publica/Pan Am J Public Heal. 2011;30(4):388-392.
46. Herrera-Franco G, Montalván-Burbano N, Mora-Frank C, Bravo-Montero, Lady. Scientific Research in Ecuador: A Bibliometric Analysis. Publications [Internet]. 2021 [citado 5 de agosto de 2025];9(4):55. Disponible en: doi:10.3390/publications9040055
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 María Fernanda Gutiérrez Bravo, Sandra Malena Alcocer Veintimilla, Víctor Andrés Pillajo Gangotena
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
